Chembio Diagnostics Inc. (CEMI)


Stock Price Forecast

April 27, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Chembio Diagnostics Inc. chart...

About the Company

Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

Exchange

NASDAQ

Website

www.chembio.com

$50M

Total Revenue

337

Employees

$17M

Market Capitalization

-0.51

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CEMI News

In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets

1d ago, source:

In Vitro Diagnostics Market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised to reach $119.4 billion by 2029, growing ...

HIV Rapid Testing Market Size Worth $6.3 Billion By 2030: IndustryARC

13d ago, source:

The Global HIV Rapid Testing Market size is predicted to reach $15.07 billion by 2030, growing at a CAGR of 7.22% during the forecast period 2024-2030 according to the latest market research report ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...